In HSV-1, the LAT Enhancer Drives Pre-IE VP16 Transcription to Initiate Reactivation

Area of Science:

• Virology
• Molecular Biology
• Epigenetics

Background:

• Herpes Simplex Virus 1 (HSV-1) establishes lifelong latency, with reactivation causing disease.
• The precise mechanisms governing HSV-1 latency and reactivation remain incompletely understood.
• The role of the viral protein VP16 in initiating lytic infection and exiting latency is a key area of investigation.

Purpose of the Study:

• To elucidate the role of CTCF insulators in regulating HSV-1 VP16 gene expression during latency and reactivation.
• To identify and characterize novel regulatory elements involved in the HSV-1 lifecycle.
• To understand the molecular basis for HSV-1 reactivation from latency.

Main Methods:

• Identification and functional characterization of a novel CTCF insulator site at the HSV-1 VP16 locus.
• Chromatin immunoprecipitation assays to assess CTCF and cohesin binding.
• Quantitative PCR to measure VP16 and other viral gene transcription.
• Analysis of long-range cis spatial interactions within the latent HSV-1 genome.

Main Results:

• A novel CTCF insulator site silences VP16 transcription during HSV-1 latency.
• CTCF and cohesin proteins are evicted from the VP16 locus upon reactivation stimulus.
• VP16 transcription precedes other viral transcription during reactivation.
• The LAT enhancer acts as a neuron-specific enhancer for VP16 transcription during reactivation.
• Long-range spatial interactions link the LAT enhancer and VP16 locus in latent HSV-1.

Conclusions:

• CTCF insulators are critical for maintaining HSV-1 latency by silencing VP16.
• VP16 transcription, driven by the LAT enhancer via long-range interactions, is a key event in HSV-1 reactivation.
• These findings reveal a VP16-dependent mechanism for exiting HSV-1 latency with implications for understanding disease heterogeneity.